Neosync's Series D Round

Neosync raised a round of funding on June 22, 2017.

NeoSync is a clinical-stage company with a proprietary platform technology being used to develop advanced, non-invasive neuromodulation products designed to treat Major Depressive Disorder and other d…

Articles about Neosync's Series D Round: